DMAC

DiaMedica Therapeutics Inc (DMAC)

US
$ 4.32.99%

Price Chart

Key Statistics

Market Cap
$ 174.42M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
27.79K
52W High
$ 6.82
52W Low
$ 2.14
Dividend Yield
0.00%
Beta
1.29

Technicals

50-Day MA
4.2875
200-Day MA
4.6881
52 Week High
6.8184
52 Week Low
2.14

About DMAC

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

Employees
27
Headquarters
Minneapolis, MN
CEO
Mr. Dietrich John Pauls MBA

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg